Ono Pharmaceutical Co., Ltd. (OPHLY)
5.16
+0.05
(+0.98%)
USD |
OTCM |
Nov 13, 16:00
Ono Pharmaceutical Total Assets (Quarterly) : 6.945B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.945B |
| June 30, 2026 | 6.672B |
| March 31, 2026 | 6.955B |
| December 31, 2025 | 6.918B |
| September 30, 2025 | 7.167B |
| June 30, 2025 | 7.086B |
| March 31, 2025 | 7.115B |
| December 31, 2024 | 6.887B |
| September 30, 2024 | 7.315B |
| June 30, 2024 | 6.737B |
| March 31, 2024 | 6.037B |
| December 31, 2023 | 6.325B |
| September 30, 2023 | 6.004B |
| June 30, 2023 | 6.032B |
| March 31, 2023 | 6.630B |
| December 31, 2022 | 6.295B |
| September 30, 2022 | 5.562B |
| June 30, 2022 | 5.625B |
| March 31, 2022 | 6.090B |
| December 31, 2021 | 6.427B |
| September 30, 2021 | 6.927B |
| June 30, 2021 | 6.693B |
| March 31, 2021 | 6.746B |
| December 31, 2020 | 6.964B |
| September 30, 2020 | 6.698B |
| Date | Value |
|---|---|
| June 30, 2020 | 6.289B |
| March 31, 2020 | 6.238B |
| December 31, 2019 | 6.066B |
| September 30, 2019 | 5.941B |
| June 30, 2019 | 5.950B |
| March 31, 2019 | 5.918B |
| December 31, 2018 | 5.737B |
| September 30, 2018 | 5.636B |
| June 30, 2018 | 5.585B |
| March 31, 2018 | 5.729B |
| December 31, 2017 | 5.293B |
| September 30, 2017 | 5.122B |
| June 30, 2017 | 5.138B |
| March 31, 2017 | 5.541B |
| December 31, 2016 | 5.002B |
| September 30, 2016 | 5.508B |
| June 30, 2016 | 5.268B |
| March 31, 2016 | 4.808B |
| December 31, 2015 | 4.416B |
| September 30, 2015 | 4.314B |
| June 30, 2015 | 4.312B |
| March 31, 2015 | 4.374B |
| December 31, 2014 | 4.217B |
| September 30, 2014 | 4.447B |
| June 30, 2014 | 4.828B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 97.19B |
| Daiichi Sankyo Co., Ltd. | 27.10B |
| Eisai Co., Ltd. | 9.703B |
| Chugai Pharmaceutical Co., Ltd. | 15.11B |
| Santen Pharmaceutical Co., Ltd. | 2.663B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.335B |
| Shareholders Equity (Quarterly) | 5.572B |
| Debt to Equity Ratio | 0.1256 |
| Current Ratio | 3.317 |
| Net Debt Paydown Yield | 0.74% |